Lanes Brands brings latest joint care supplement to U.S. market

BEDFORD, N.H. - With the February launch of GOPO Rosehip with Galactolipids, a joint care supplement clinically proven to support joint health, Lanes Brands on Monday reported the natural supplement is gaining traction in the U.S. Used extensively in Europe, GOPO has been proven effective in supporting long-term joint mobility and cartilage care, the company stated.



“GOPO has been helping joint pain sufferers in other countries for many years,” said Jonathan Groves, president at Lanes Brands. “The number of people experiencing joint problems is increasing and more effective solutions have not been available to them, until now.”



GOPO Rosehip with Galactolipids is made from 100% specially-cultivated, natural rosehip using a patented extraction process and is the only product of its kind to contain a high level of galactolipids - a key component of the rosehip which may play a valuable role in the care of joints and joint tissues.



“GOPO is not a drug, but an all-natural supplement that you can feel safe taking for long-term joint care,” stated Kaj Winther, clinical biologist and expert in studies of Rosehips for joint support. According to Winther, at just 3 weeks, 8 out of 10 users reported positive results with no reported side effects.



The supplement is now available nationally in major retailers including Walgreens, Meijer, Kroger, The Vitamin Shoppe and Amazon.com.



GOPO has been evaluated in several placebo-controlled, clinical trials involving hundreds of patients with painful joints. Efficacy results have been consistently positive and evidence supporting the benefits of GOPO has been presented around the world at clinical meetings and published in peer-reviewed journals.